PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Q3 2022 Earnings Call Conference Call November 3, 2022 4:30 PM ET

Company Participants

Matt Bacso – Vice President-Investor Relations

Reza Zadno – Chief Executive Officer

Kevin Waters – Senior Vice President and Chief Financial Office

Conference Call Participants

Craig Bijou – BofA Securities

Nathan Treybeck – Wells Fargo

Richard Newitter – Truist Securities

Ryan Zimmerman – BTIG

Neil Chatterji – B. Riley

Matthew Mishan – KeyBanc

Philip Coover – Goldman Sachs

Joshua Jennings – Cowen

Operator

Good day. And thank you for standing by. Welcome to the Q3 2022 PROCEPT BioRobotics’ Earnings Conference Call. [Operator instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Matt Bacso, Vice President of Investor Relations. Please go ahead.

Matt Bacso

Thanks, operator. Good afternoon, and thank you for participating in today's call. Joining me are Reza Zadno, CEO; and Kevin Waters, CFO.

Earlier today, PROCEPT released financial results for the quarter ended September 30, 2022. A copy of the press release is available on the company's website.

Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements contained in this call that relate to expectations or predictions of future events, results or performance are forward-looking statements. All forward-looking statements, including, without limitations, those related to our sales and operating trends and future financial performance, expense management, expectations for hiring or growth, market opportunity, revenue guidance, commercial expansion and future product development and approvals are based upon our current estimates and various assumptions.

These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those implied by these forward-looking statements. Accordingly, you should not place undue reliance on these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of our most recent annual report on Form 10-K filed with the Securities and Exchange Commission on March 22, 2022, and in our other public reports filed periodically with the SEC. This conference call contains time-sensitive information and is accurate only as of the live broadcast on November 3, 2022.

PROCEPT BioRobotics disclaims any intention or obligation, except as required by law, to update or revise any financial projections or forward-looking statements whether because of new information, future events or otherwise.